RAPT Therapeutics earnings missed by $0.07, revenue was in line with estimates

  • Investing.com
RAPT Therapeutics earnings missed by $0.07, revenue was in line with estimates

Investing.com - RAPT Therapeutics (NASDAQ: RAPT ) reported third quarter EPS of $-0.82, $0.07 worse than the analyst estimate of $-0.75. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.

RAPT Therapeutics's stock price closed at $11.73. It is down -39.16% in the last 3 months and down -48.84% in the last 12 months.

RAPT Therapeutics saw 5 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See RAPT Therapeutics's stock price’s past reactions to earnings here.

According to InvestingPro, RAPT Therapeutics's Financial Health score is "fair performance".

Check out RAPT Therapeutics's recent earnings performance , and RAPT Therapeutics's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles